SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-17-002044
Filing Date
2017-11-16
Accepted
2017-11-16 16:05:30
Documents
1
Group Members
AISLING CAPITAL II, LPAISLING CAPITAL PARTNERS LLCAISLING CAPITAL PARTNERS, LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 eh1701147_13da3-adma.htm SC 13D/A 155540
  Complete submission text file 0000950142-17-002044.txt   157287
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Filed by) CIK: 0001350778 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82025 | Film No.: 171208075
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences